Immunosuppressant mycophenolate mofetil for patients with steroid-refractory immune-related hepatitis induced by checkpoint inhibitors in oncology
European Journal of Cancer · 2023
DOI: 10.1016/j.ejca.2023.113313 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2023. Verfasst von Emily Alouani und 18 weiteren Autor:innen. Beteiligte Einrichtung: Département d'Innovation Thérapeutique et Essais Précoces, Gustave Roussy - Paris-Saclay University, Villejuif, France; Digestive Medical Oncology De…. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Mycophenolic Acid, Immunosuppressive Agents, Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Département d'Innovation Thérapeutique et Essais Précoces, Gustave Roussy - Paris-Saclay University, Villejuif, France; Digestive Medical Oncology Department, IUCT-Rangueil, Toulouse Hospital University, Toulouse, Franc…
- Département Interdisciplinaire d'Organisation des Parcours Patients, Gustave Roussy - Paris-Saclay University, Villejuif, France.
- Département d'Innovation Thérapeutique et Essais Précoces, Gustave Roussy - Paris-Saclay University, Villejuif, France.
- Pharmacovigilance Unit, Gustave Roussy - Paris-Saclay University, Villejuif, France.
- Département d'Innovation Thérapeutique et Essais Précoces, Gustave Roussy - Paris-Saclay University, Villejuif, France; INSERM U1015 and CIC1428 BIOTHERIS, Gustave Roussy, Villejuif, France.
- Department of Medical Oncology, Gustave Roussy - Paris-Saclay University, Villejuif, France.
Zitieren
APA
Alouani, E., Laparra, A., Perret, A., Sakkal, M., Messayke, S., Danlos, F. X., Ouali, K., Hollebecque, A., Even, C., Ammari, S., Baldini, C., Champiat, S., Besse, B., Robert, C., Guettier, C., Samuel, D., Lambotte, O., De Martin, E., & Michot, J. M. (2023). Immunosuppressant mycophenolate mofetil for patients with steroid-refractory immune-related hepatitis induced by checkpoint inhibitors in oncology. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2023.113313
Vancouver
Alouani E, Laparra A, Perret A, Sakkal M, Messayke S, Danlos FX, et al. Immunosuppressant mycophenolate mofetil for patients with steroid-refractory immune-related hepatitis induced by checkpoint inhibitors in oncology. European Journal of Cancer. 2023. doi:10.1016/j.ejca.2023.113313
BibTeX
@article{Alouani2023,
author = {Alouani, Emily and Laparra, Ariane and Perret, Audrey and Sakkal, Madonna and Messayke, Sabine and Danlos, Francois-Xavier and Ouali, Kaissa and Hollebecque, Antoine and Even, Caroline and Ammari, Samy and Baldini, Capucine and Champiat, Stéphane and Besse, Benjamin and Robert, Caroline and Guettier, Catherine and Samuel, Didier and Lambotte, Olivier and De Martin, Eleonora and Michot, Jean-Marie},
title = {Immunosuppressant mycophenolate mofetil for patients with steroid-refractory immune-related hepatitis induced by checkpoint inhibitors in oncology},
journal = {European Journal of Cancer},
year = {2023},
doi = {10.1016/j.ejca.2023.113313}
}
EUVIMED